FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD - News), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today reported financial results for its year ended December 31, 2007. For the year ended December 31, 2007, the Company reported a net loss of $17.0 million, or $0.29 cents per share, compared to a net loss of $9.5 million, or $0.20 cents per share, for the unaudited year ended December 31, 2006.
